Anthera Pharmaceuticals (ANTH) News Today → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free ANTH Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMACK - Merrimack Pharmaceuticals, Inc.finance.yahoo.com - June 28 at 11:05 PMIndustry Research Report on Cystic Fibrosis Drugs Market Share and Industrial Overview till 2030marketwatch.com - May 16 at 5:08 PMSystemic Lupus Erythematosus (SLE) Drugs Market Updates: 2023-2030 Forecastmarketwatch.com - May 16 at 8:49 AM2023-2030 Vasculitis Treatment Market Size (Growth and Outlook) includes Main Business Overview | with [124 Pages]marketwatch.com - May 5 at 1:55 PM2023-2030 Gaucher Disease Treatment Market Size (Growth and Outlook) includes Company Information | with [104 Pages]marketwatch.com - May 4 at 12:49 PMGaucher Disease Treatment Market Top Key Players by 2030marketwatch.com - April 28 at 10:21 PMGlobal Cystic Fibrosis Drugs Market Size 2023 to 2026 Size and Share Survey Reportmarketwatch.com - April 7 at 5:45 PMCeliac Disease Drug Market Size and Forecast till 2030marketwatch.com - March 28 at 9:59 AMCystic Fibrosis Drugs Market 2023-2028 Recent Study by Trend and Growth Analysismarketwatch.com - March 10 at 9:56 PMInfectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc.finance.yahoo.com - March 8 at 7:25 AMTwo Drugs, Designed To Help Patients, Actually Hurt Themthestreet.com - February 26 at 12:51 AMGaucher Disease Treatment Market Provides an In-Depth Insight of Trends and Landscape Outlook 2023-2028marketwatch.com - January 13 at 8:46 AMCeliac Drugs Market Trends, Business Overview, Industry Growth, and Forecast 2023 To 2028marketwatch.com - January 7 at 1:23 PMGaucher Disease Treatment Market Research report forecast 2023 To 2028, Latest Industry News, Top Company Analysis, Research Methodologymarketwatch.com - December 17 at 11:36 PMCystic Fibrosis Drugs Market 2022 | Upcoming Trends, Recent Development, Top Manufacturers, Industry Drivers and Forecast to 2028marketwatch.com - October 12 at 1:49 PMThryv Therapeutics Inc. Announces the Appointment of Dr. Debra Odink to President and Dr. Shi Yin Foo to the Board of Directorsapnews.com - September 1 at 2:19 PMANTH.PQ - Anthera Pharmaceuticals Inc | Stock Price & Latest News | Reutersreuters.com - August 26 at 9:13 PMAnthera Pharmaceuticals (OTC:ANTH), Short Interest Reportbenzinga.com - June 10 at 11:36 AMVasculitis Treatment Market Size 2022 including Scope, Trends, Manufacturers, Growth Factors, Market Dynamics and Forecast to 2028marketwatch.com - May 10 at 7:21 PMThe Petri Dish: Two startups get new CEOs, workforce dev coalition ramps upbizjournals.com - April 21 at 9:34 AMNervGen Pharma Corp.: NervGen Pharma Appoints Craig Thompson to the Board of Directorsfinanznachrichten.de - April 14 at 11:01 PMNervGen Pharma Appoints Craig Thompson to the Board of Directorsfinance.yahoo.com - April 13 at 10:58 AMSanthera Pharmaceuticals Holding AG: Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD Studyfinanznachrichten.de - November 24 at 6:42 PMAnthera Pharmaceuticals, Inc. (ANTH)sg.finance.yahoo.com - October 26 at 5:02 AMEPI Market 2021 : Global Industry Analysis, Trends, Market Size and Forecasts Up to 2025 with Dominant Sectors and Countries Datamarketwatch.com - October 4 at 7:19 PMHemoglobinopathies Market Revenue Growth, New Launches, Regional Share Analysis & Forecast Till 2027marketwatch.com - August 12 at 2:55 AMAnthera Pharmaceuticals Inc (ANTH)nasdaq.com - August 2 at 8:27 PMAnthera Pharmaceuticals Inc.barrons.com - August 2 at 8:27 PMSystemic Lupus Erythematous Sle Drugs Market Size 2021 to 2026 Segmentation at Region Level Including Market Revenue, Share and Price Analysismarketwatch.com - July 23 at 5:38 PM Get Anthera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANTH and its competitors with MarketBeat's FREE daily newsletter. Email Address 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (Ad)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency ANTH Media Mentions By Week ANTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANTH News Sentiment▼0.000.63▲Average Medical News Sentiment ANTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANTH Articles This Week▼00▲ANTH Articles Average Week Get Anthera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADCT News Today BAYRY News Today IMUC News Today GNMSF News Today GRFS News Today HYPMY News Today IMVIQ News Today ISCO News Today LVTX News Today MYNZ News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ANTH) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anthera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.